First Vaccine Trial Shows Positive Results

Global markets are on the rise this morning as hopes for the development of a virus vaccine intensify once again. The first vaccine tested by Moderna and the U.S. National Institutes of Health uncovered an encouraging immune system boost, paving the way for an even larger study to see if the drug is powerful enough to protect against the virus.

Profit From the Future With Artificial Intelligence

Technology has really made a name for itself, and now, investors are beginning to take artificial intelligence very seriously… Just look at the numbers! The global artificial intelligence market is worth a whopping $400 billion and is expected to grow another 20% before 2025.

Most Investors Miss This Major Warning Sign

Global markets are rather mixed this morning as virus cases continue to rise against positive economic data in the U.S. and countries across Europe.

Numbers That Are Too Good to Be True

Despite sentiment appearing fragile as virus infections remain strong in many countries -- including the U.S.-- global stocks are surprisingly higher this morning.

Will Optimism Undermine the Economic Recovery?

Global markets are conflicted this morning as concerns over the pandemic rise, exhausting almost all the buying enthusiasm that’s recently pushed prices higher.

If You’re Trading the Nasdaq… Watch Out

Despite an overnight rally in tech shares and the Nasdaq hitting another all-time high, global markets slipped this morning as the pandemic dimmed hopes for a worldwide recovery.

Stocks Rise Despite Climbing Virus Cases

Global markets and U.S. shares are on the rise this morning as investors disregard the surge in new virus cases in heavily populated areas around the world, choosing instead to set their sights on an economic recovery.

2 Stocks Heating Up For Summer Investing

We’re watching some pretty sharp events take place. In the past six months alone, we’ve seen a nasty trade war with China and a global pandemic. But there’s more where that came from…

Markets Rise on Hopes for Virus Vaccine

Global markets and Wall Street are on the rise this morning as hopes for the development of a virus vaccine intensify. In fact, many investors are optimistic after Pfizer and BioNTech announced positive data from an early-stage vaccine trial, but meanwhile states like California and Texas are reporting record highs in new cases.